TrialPloS one2019

Implant for Augmentation of Cerebral Blood Flow Trial-1 (ImpACT-1). A single-arm feasibility study evaluating the safety and potential benefit of the Ischemic Stroke System for treatment of acute ischemic stroke.

Dheeraj Khurana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.